Ashvattha’s new self-administered anti-VEGF therapy may address unmet needs for DME Pharmaceutical Technology
Safety data for at-home subcutaneous injection option for treatment of wet AMD, DME Ophthalmology Times
Phase 1 safety data for subcutaneous anti-VEGF candidate for wet AMD, DME presented at ARVO Moderna Retina
Neurologists test novel compound for lung and brain injury in severe COVID-19 patients UT Health Houston News